Shares of SiBone (NASDAQ:SIBN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and seven have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $25.00.
Several equities analysts recently commented on SIBN shares. Truist Financial upped their target price on SiBone from $23.00 to $25.00 and gave the company a "buy" rating in a research note on Wednesday, October 14th. TD Cowen raised their price target on SiBone from $20.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, November 3rd. Wall Street Zen upgraded SiBone from a "hold" rating to a "buy" rating in a report on Saturday, November 7th. UBS Group lifted their price target on SiBone from $25.00 to $26.00 and gave the company a "buy" rating in a report on Tuesday, November 3rd. Finally, Citigroup reaffirmed a "market outperform" rating on shares of SiBone in a research note on Tuesday, November 3rd.
Get Our Latest Analysis on SIBN
Insider Activity at SiBone
In related news, Director Jeffrey W. Dunn sold 20,000 shares of the business's stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $20.89, for a total value of $417,800.00. Following the completion of the sale, the director directly owned 16,057 shares in the company, valued at approximately $335,430.73. The trade was a 55.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Anshul Maheshwari sold 3,247 shares of the business's stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $25.00, for a total transaction of $81,175.00. Following the completion of the sale, the insider owned 211,250 shares of the company's stock, valued at approximately $5,281,250. The trade was a 1.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 364,469 shares of company stock valued at $7,877,769 over the last three months. Insiders own 4.00% of the company's stock.
Institutional Trading of SiBone
Several institutional investors have recently made changes to their positions in the stock. Versant Capital Management Inc increased its holdings in shares of SiBone by 102.9% during the 2nd quarter. Versant Capital Management Inc now owns 1,749 shares of the company's stock worth $29,000 after buying an additional 887 shares during the last quarter. D.A. Davidson & CO. boosted its holdings in SiBone by 2.8% in the third quarter. D.A. Davidson & CO. now owns 37,814 shares of the company's stock valued at $711,000 after acquiring an additional 1,038 shares during the last quarter. State of Wyoming boosted its holdings in SiBone by 70.8% in the first quarter. State of Wyoming now owns 10,832 shares of the company's stock valued at $137,000 after acquiring an additional 4,490 shares during the last quarter. Diversified Trust Co boosted its holdings in SiBone by 26.0% in the third quarter. Diversified Trust Co now owns 34,775 shares of the company's stock valued at $654,000 after acquiring an additional 7,165 shares during the last quarter. Finally, Marshall Wace LLP grew its position in SiBone by 1.2% during the third quarter. Marshall Wace LLP now owns 698,416 shares of the company's stock valued at $13,130,000 after acquiring an additional 8,128 shares during the period. 98.11% of the stock is owned by hedge funds and other institutional investors.
SiBone Stock Performance
Shares of NASDAQ SIBN opened at $23.41 on Tuesday. The company has a 50-day simple moving average of $20.47 and a 200-day simple moving average of $16.82. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.58 and a quick ratio of 6.15. The company has a market cap of $1.06 billion, a PE ratio of -75.51 and a beta of 0.64. SiBone has a 12 month low of $11.48 and a 12 month high of $25.92.
SiBone (NASDAQ:SIBN - Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.05. SiBone had a negative net margin of 6.20% and a negative return on equity of 7.57%. The business had revenue of $55.70 million for the quarter, compared to the consensus estimate of $55.31 million. On average, equities analysts anticipate that SiBone will post -0.34 earnings per share for the current year.
SiBone Company Profile
(
Get Free Report)
SI-BONE, Inc. is a medical technology company focused on surgical solutions for conditions affecting the sacroiliac (SI) joint and related pelvic anatomy. Founded in 2008, the company develops implants and instruments used by surgeons in procedures involving the SI joint. Its products include the iFuse Implant System, a minimally invasive approach to SI joint fusion, along with related implant systems designed for SI joint and pelvic fixation procedures. SI-BONE also offers surgical instruments and training resources for healthcare professionals.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SiBone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SiBone wasn't on the list.
While SiBone currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.